rs17249437

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001172.4(ARG2):​c.185-8016T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.408 in 152,052 control chromosomes in the GnomAD database, including 15,208 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.41 ( 15208 hom., cov: 31)

Consequence

ARG2
NM_001172.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.00400

Publications

8 publications found
Variant links:
Genes affected
ARG2 (HGNC:664): (arginase 2) Arginase catalyzes the hydrolysis of arginine to ornithine and urea. At least two isoforms of mammalian arginase exists (types I and II) which differ in their tissue distribution, subcellular localization, immunologic crossreactivity and physiologic function. The type II isoform encoded by this gene, is located in the mitochondria and expressed in extra-hepatic tissues, especially kidney. The physiologic role of this isoform is poorly understood; it is thought to play a role in nitric oxide and polyamine metabolism. Transcript variants of the type II gene resulting from the use of alternative polyadenylation sites have been described. [provided by RefSeq, Jul 2008]
GPHN (HGNC:15465): (gephyrin) This gene encodes a neuronal assembly protein that anchors inhibitory neurotransmitter receptors to the postsynaptic cytoskeleton via high affinity binding to a receptor subunit domain and tubulin dimers. In nonneuronal tissues, the encoded protein is also required for molybdenum cofactor biosynthesis. Mutations in this gene may be associated with the neurological condition hyperplexia and also lead to molybdenum cofactor deficiency. Numerous alternatively spliced transcript variants encoding different isoforms have been described; however, the full-length nature of all transcript variants is not currently known. [provided by RefSeq, Jul 2008]
GPHN Gene-Disease associations (from GenCC):
  • sulfite oxidase deficiency due to molybdenum cofactor deficiency type C
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, ClinGen
  • hereditary hyperekplexia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.684 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001172.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ARG2
NM_001172.4
MANE Select
c.185-8016T>C
intron
N/ANP_001163.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ARG2
ENST00000261783.4
TSL:1 MANE Select
c.185-8016T>C
intron
N/AENSP00000261783.3
ARG2
ENST00000556491.1
TSL:5
n.183-8016T>C
intron
N/A
ARG2
ENST00000557120.5
TSL:2
n.227-8016T>C
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.407
AC:
61885
AN:
151934
Hom.:
15157
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.690
Gnomad AMI
AF:
0.137
Gnomad AMR
AF:
0.431
Gnomad ASJ
AF:
0.299
Gnomad EAS
AF:
0.454
Gnomad SAS
AF:
0.358
Gnomad FIN
AF:
0.289
Gnomad MID
AF:
0.421
Gnomad NFE
AF:
0.257
Gnomad OTH
AF:
0.423
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.408
AC:
62014
AN:
152052
Hom.:
15208
Cov.:
31
AF XY:
0.407
AC XY:
30248
AN XY:
74338
show subpopulations
African (AFR)
AF:
0.691
AC:
28624
AN:
41444
American (AMR)
AF:
0.432
AC:
6599
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.299
AC:
1036
AN:
3466
East Asian (EAS)
AF:
0.454
AC:
2343
AN:
5166
South Asian (SAS)
AF:
0.360
AC:
1738
AN:
4828
European-Finnish (FIN)
AF:
0.289
AC:
3052
AN:
10574
Middle Eastern (MID)
AF:
0.422
AC:
124
AN:
294
European-Non Finnish (NFE)
AF:
0.257
AC:
17470
AN:
67978
Other (OTH)
AF:
0.428
AC:
903
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1634
3268
4902
6536
8170
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
558
1116
1674
2232
2790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.363
Hom.:
1631
Bravo
AF:
0.435
Asia WGS
AF:
0.435
AC:
1514
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
2.5
DANN
Benign
0.63
PhyloP100
0.0040
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17249437; hg19: chr14-68100887; API